Skip to main content

Table 1 Patient characteristics and perioperative outcomes

From: 99mTc-GSA scintigraphy and modified albumin–bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure

N

413

Preoperative factors

 Age, yearsa

69.0 [59.0, 75.0]

 Male, genderb

262 (63.4%)

 ASA-PS, n (1/2/3/4)

48/339/26/0

Child–Pugh classificationb

 A

392 (94.9)

 B

18 (4.4)

 C

3 (0.7)

 MELD scorea

6.76 [6.20, 7.70]

 ALBI scorea

 − 2.52 [− 2.78, − 2.25]

 mALBI grade, n (1/2a/2b/3)

171/135/95/12

 ICG-R15, %a

11.9 [7.8, 17.5]

 LHL15a

0.92 [0.90, 0.94]

Esophagogastric varicesb

 ( −)

352 (85.2)

 ( +)

61 (14.8)

Intraoperative factors

 Approachb

 Open

125 (30.3)

 Laparoscopic

237 (57.4)

 Robotic

51 (12.3)

Extent of hepatectomyb

 Hr0

188 (45.5)

 HrS

83 (20.1)

 Hr1

69 (16.7)

 Hr2

64 (15.5)

 Hr3

9 (2.2)

Major hepatectomyb

 No

271 (65.6)

 Yes

142 (34.4)

 Operation time, mina

534.0 [360.0, 692.0]

 Blood loss, mLa

220.0 [75.0, 640.0]

 LOS, daya

15.0 [11.0, 20.0]

Pathological diagnosisb

 HCC

208 (50.4)

 CCC

21 (5.1)

 Metastatic

150 (36.3)

 Gallbladder cancer

2 (0.5)

 FNH

4 (1.0)

 Othersc

28 (6.8)

Postoperative factors

 Morbidityb

  IIIA > 

371 (89.8)

  IIIA ≤ 

42 (10.2)

 PHLFb

  ( +)

66 (16.0)

  A

20 (4.8)

  B

44 (10.7)

  C

2 (0.5)

  1. Continuous variables showed a nonnormal distribution and are presented as median and interquartile range. Hr1, 2, and 3 were classified as major hepatectomy
  2. Morbidities after surgery during the same hospital stay were categorized according to Dindo and colleagues
  3. ASA-PS American Society of Anesthesiologists physical status, MELD score Model for End Liver Disease, ICG-R15 indocyanine green retention rate at 15 min, LHL15 radioactivity of the heart and liver after intravenous injection of 99mTc-GSA, Hr0 partial resection, HrS subsegmentectomy, Hr1 segmentectomy, Hr2 lobectomy and central bisegmentectomy, Hr3 trisectomy and caudate lobectomy, LOS length of hospital stay after surgery, HCC hepatocellular carcinoma, CCC cholangiocellular carcinoma, FNH focal nodular hyperplasia, PHLF posthepatectomy liver failure
  4. aValues are presented as median (interquartile range)
  5. bValues are presented as number (%)
  6. cDetails of 28 other cases: hemorrhagic cyst, inflammatory pseudotumor, mucinous cystic tumor, pseudo lymphoma, epithelioid granuloma with necrosis, angiomyolipoma, cholangiocellular adenoma, cholangiectasis, hepatocellular adenoma malignant transformation, undifferentiated sarcoma, undifferentiated hepatocellular carcinoma, two cases of intraductal papillary neoplasia of the bile duct, two cases of hepatoblastoma, two cases of cholangiocyst, two cases of hepatocellular adenoma, and nine cases of hemangioma